Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$16.61 USD
-0.27 (-1.60%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $16.62 +0.02 (0.12%) 4:16 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 0.57 |
EPS Last Quarter | 0.48 |
Last EPS Surprise | -5.88% |
ABR | 1.44 |
Earnings ESP
|
0.70% |
---|---|
Current Year | 2.44 |
Next Year | 2.71 |
EPS (TTM) | 2.64 |
P/E (F1) | 6.93 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.98B | 3.96B | 15.93B | 16.53B |
# of Estimates | 5 | 5 | 4 | 4 |
High Estimate | 4.07B | 4.06B | 16.10B | 17.01B |
Low Estimate | 3.83B | 3.82B | 15.87B | 16.23B |
Year ago Sales | 3.88B | 3.85B | 15.85B | 15.93B |
Year over Year Growth Est. | 2.57% | 2.84% | 0.55% | 3.77% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.57 | 0.61 | 2.44 | 2.71 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.58 | 0.59 | 2.35 | 2.59 |
High Estimate | 0.61 | 0.67 | 2.67 | 2.93 |
Low Estimate | 0.53 | 0.54 | 2.31 | 2.59 |
Year ago EPS | 0.56 | 0.60 | 2.56 | 2.44 |
Year over Year Growth Est. | 1.79% | 1.67% | -4.69% | 11.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 2 | 4 | 3 | 3 |
Up Last 60 Days | 2 | 4 | 4 | 4 |
Down Last 7 Days | 2 | 0 | 1 | 1 |
Down Last 30 Days | 2 | 0 | 0 | 2 |
Down Last 60 Days | 2 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.57 | 0.61 | 2.44 | 2.71 |
7 Days Ago | 0.59 | 0.61 | 2.43 | 2.70 |
30 Days Ago | 0.58 | 0.59 | 2.37 | 2.67 |
60 Days Ago | 0.58 | 0.59 | 2.37 | 2.61 |
90 Days Ago | 0.58 | 0.59 | 2.37 | 2.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.57 | 0.63 | 2.47 | 2.72 |
Zacks Consensus Estimate | 0.57 | 0.61 | 2.44 | 2.71 |
Earnings ESP | 0.70% | 2.80% | 1.23% | 0.22% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.48 | 1.00 | 0.60 | 0.56 | NA |
Estimate | 0.51 | 0.75 | 0.60 | 0.54 | NA |
Difference | -0.03 | 0.25 | 0.00 | 0.02 | 0.06 |
Surprise | -5.88% | 33.33% | 0.00% | 3.70% | 7.79% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more